Minecoside is isolated from the barks of Kigelia pinnata. It is an antioxidant with anti-inflammatory and anticancer properties. Minecoside has been shown to inhibit the growth of cancer cells in vitro, as well as to prevent the development of cancer in animals. This product can be used for research in the fields of medicine, pharmacy, cosmetics and agriculture.
Molecular Weight
538.5
Molecular Formula
C25H30O13
Source
Kigelia pinnata
Part Used
Barks
Form
Powder
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Applications
Minecoside can be used for research in the fields of medicine, pharmacy, cosmetics and agriculture.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.